Quantcast
Last updated on April 21, 2014 at 7:52 EDT

Synthesis Polypeptide Drug Market (Global and China) Research Report for 2012

November 30, 2012

DALLAS, November 30, 2012 /PRNewswire/ –

RnRMarketResearch.com adds new market research report “2012 Deep Research Report on
Global and China Synthesis Polypeptide Drug Industry” to its store.

2012 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry is a
professional and in-depth research report on China Synthesis Polypeptide Drug market. The
report introduces Synthesis Polypeptide Drug with basic information including definition,
classification, application, industry chain structure, industry overview and more. The
research covers international market analysis, China domestic market analysis,
Macroeconomic environment and economic situation analysis and influence, Synthesis
Polypeptide Drug industry
[http://www.rnrmarketresearch.com/2012-deep-research-report-on-global-and-china-synthesis-polypeptide-drug-industry-market-report.html ]
policy and plan, Synthesis Polypeptide Drug
product specification, manufacturing process, product cost structure, etc. Statistics of
China’s key manufacturers of Synthesis Polypeptide Drug with their capacity production
cost price profit production value gross margin and other details are also covered. In
addition to the above said information, the study also presents products and their
customers, application, capacity, market position, company contact information and other
related information of these companies. The report also covers all these manufacturers’
data and lists China Synthesis Polypeptide Drug capacity production capacity market share
production market share supply demand shortage import export consumption etc data
statistics, and then introduced China Synthesis Polypeptide Drug 2009-2013 capacity
production price cost profit production value gross margin etc information. And also lists
Synthesis Polypeptide Drug upstream raw materials equipments and Sharp Solarnstream
clients alternative products survey analysis and Synthesis Polypeptide Drug marketing
channels industry development trend and proposals. In the end, this report introduced
Synthesis Polypeptide Drug new project SWOT analysis Investment feasibility analysis
investment return analysis and also give related research conclusions and development
trend analysis of China Synthesis Polypeptide Drug industry. In a word, it was a depth
research report on China Synthesis Polypeptide Drug industry. And thanks to the support
and assistance from Synthesis Polypeptide Drug industry chain related technical experts
and marketing engineers during Research Team survey and interviews.

Buy your copy of this report @

http://www.rnrmarketresearch.com/contacts/purchase?rname=57872

Table of Contents for the report “2012 Deep Research Report on Global and China
Synthesis Polypeptide Drug Industry” cover:

        Chapter One Synthesis Polypeptide Drug Industry Overview    1
        1.1 Synthesis Polypeptide Drug Definition    1
        1.2 Synthesis Polypeptide Drug Classification and Application    3
        1.3 Professional Terms Interpretation    8
        1.4 Synthesis Polypeptide Drug Industry Chain Structure    12
        1.5 Synthesis Polypeptide Drug Industry Overview    14
        Chapter Two Synthesis Polypeptide Drug International and China Market Analysis    16
        2.1 Synthesis Polypeptide Drug Industry International Market Analysis    16
        2.1.1 Synthesis Polypeptide Drug International Market Development History    16
        2.1.2 Synthesis Polypeptide Drug Product and Technology Developments    18
        2.1.3 Synthesis Polypeptide Drug Competitive Landscape Analysis    25
        2.1.4 Synthesis Polypeptide Drug International Key Countries Development Status    28
        2.1.5 Synthesis Polypeptide Drug International Market Development Trend    30
        2.2 Synthesis Polypeptide Drug China Market Analysis    33
        2.2.1 Synthesis Polypeptide Drug China Market Development History    33
        2.2.2 Synthesis Polypeptide Drug Product and Technology Developments    33
        2.2.3 Synthesis Polypeptide Drug Competitive Landscape Analysis    35
        2.2.4 Synthesis Polypeptide Drug China Key Regions Development Status    37
        2.2.5 Synthesis Polypeptide Drug China Market Development Trend    37
        2.3 Synthesis Polypeptide Drug International and China Market Comparison Analysis    42
        Chapter Three Major Synthesis Polypeptide Drug Analysis    43
        3.1 Immunity Regulating Medicine (Allergy Infection and Immune)    43
        3.1.1 Glatiramer Injection (Glatiramer Acetate)    43
        3.1.2 Thymalfasin for Injection    46
        3.1.3 Thymopentin Injection    49
        3.1.4 Thymopetidum Injection    53
        3.1.5 Summary    55
        3.2 Digestive System Drugs (Gastrointestinal Type)    57
        3.2.1 Octreotide Acetate Injection    57
        3.2.2 Somatostatin for Injection    61
        3.3 Bone and Connective Tissue Types (Thyroid hormones Drug)    66
        3.3.1 Salmon Calcitonin Injection    67
        3.3.2 Elcatonin Injection    70
        3.3.4 TerfparaLide Injectlon    72
        3.4 Gynecologic or Obstetric Drug    76
        3.4.1 Oxytocin Injection    76
        3.4.2 Carbetocin Injection    81
        3.4.3 Acetate Atosiban Injection    83
        3.5 Tumor Drug (hCG)    86
        3.5.1 Leuprorelin Acetate Microspheres for Injection    87
        3.5.2 Goserelin Acetate    89
        3.5.3 Triptorelin Acetate Injection    92
        3.5.4 Chorionic Gonadotrophin for Injection    95
        3.6 Urinary System Drug (Diabetes Insipidus)    98
        3.6.1 Desmopressin Acetate Injection    98
        3.6.2 Terlipressin for Injection    101
        3.7 Metabolic Drug (Insulin and Other Hypoglycemic Agents)    105
        3.7.1 Biosynthetic Glucagon for Injection    105
        3.7.2 Exenatide Injection    106
        Chapter Four Synthesis Polypeptide Drug Development Environmental Analysis    109
        4.1 China's Macroeconomic Environmen
        t Analysis    109
        4.1.1 China GDP Analysis    109
        4.1.2 China CPI Analysis    111
        4.2 European Economic Environmental Analysis and Impact    113
        4.3 United States Economic Environmental Analysis and Impact    116
        4.4 Japan Economic Environmental Analysis and Impact    119
        4.5 Global Economic Environmental Analysis and Impact    120
        4.5.1 Global Economic Environmental Analysis    120
        4.5.2 Global Economic Influence    121
        Chapter Five Synthesis Polypeptide Drug Development Policy and Plan    121
        5.1 China Government Policy and Development Plan    121
        5.2 Industry Policy and Standard    122
        5.3 Technical Standard    125
        5.4 Technology Replacement and R&D Trends    126
        5.5 Hotspots and Influence    127
        Chapter Six Synthesis Polypeptide Drug Manufacturing Process and Cost Structure    132
        6.1 Synthesis Polypeptide Drug Manufacturing Process Overview    132
        6.2 Synthesis Polypeptide Drug Manufacturing Process Analysis    135
        6.3 Synthesis Polypeptide Drug Cost Structure Analysis    138
        Chapter Seven 2009-2013 Synthesis Polypeptide Drug Productions Supply Sales Demand
         Market Status and Forecast    140
        7.1 2009-2013 Synthesis Polypeptide Drug Capacity Production Overview    140
        7.1.1 2009-2013 Global and China Synthesis Polypeptide Drug Capacity Production    140
        7.1.2 2009-2013 Synthesis Polypeptide Drug Production Market Share    146
        7.1.3 2009-2013 Synthesis Polypeptide Drug Demand Overview    152
        7.1.4 2009-2013 Synthesis Polypeptide Drug Supply Demand and Shortage    152
        7.1.5 2009-2013 Synthesis Polypeptide Drug Production Import Export Consumption    153
        7.1.6 2009-2013 Synthesis Polypeptide Drug Cost Price Production Value Gross Margin
         154
        7.2 Different Type Synthesis Polypeptide Drug Sales and Market Scale Analysis    156
        7.2.1Thymopentin Injection    156
        7.2.2 Thymalfasin Injection    158
        7.2.3 Calcitonin Injection    159
        7.2.4 Somatostatin for Injection    161
        7.2.5Octreotide Acetate Injection    162
        7.2.6 Desmopressin Acetate Injection    163
        7.3 Synthesis Polypeptide Drug Market Summary    165
        Chapter Eight Synthesis Polypeptide Drug Key Manufacturers (Company Profiles
         [http://www.rnrcompanyprofiles.com ])   170
        8.1 Novartis    170
        8.2 Merck Serono    176
        8.3 Ferring Pharmaceuticals    181
        8.4 Ipsen PHarma Biotech    188
        8.5 Lilly    191
        8.6 Asahi Kasei    195
        8.7 AstraZeneca    199
        8.8 SciClone Pharmaceuticals    203
        8.9 Takeda    206
        8.10 HYBIO Pharmaceutical Co.,Ltd (Shenzhen Stock:300199)    210
        8.11 Hainan Zhonghe Pharmaceutical Co.,Ltd    215
        8.12 Sichuan Chengdu Diao Pharmaceutical Group Co.,Ltd    219
        8.13 Beijing Yingu Century Pharmaceutical Co.,Ltd (Beijing Shiqiao Bio-Pharmaceutical
         Co.,Ltd)    224
        8.14 Hainan Shuangcheng Pharmaceuticals Co.,Ltd    227
        8.15 Livzon Pharmaceuticals Co.,Ltd (Livzon:000513)    234
        8.16 Wuhan Hualong Bio-Chemical Pharmaceutical Co.,Ltd    238
        8.17 Chengdu Tiantaishan Pharmaceutical Co.,Ltd    242
        8.18 Beijing Shuanglu Pharmaceutical Co.,Ltd    250
        8.19 Yangzijiang Pharmaceutical Co.,Ltd    257
        8.20 Changzhou Siyao Pharmaceutical Co.,Ltd    262
        Chapter Nine Up and Down Stream Industry Analysis and Influence    267
        9.1 Upstream Raw Materials Price Analysis and Influence    267
        9.1 Upstream Equipments Market Analysis and Influence    269
        9.3 Downstream Demand Analysis and Influence    270
        9.4 Industry Policy Analysis and Influence    271
        Chapter Ten Synthesis Polypeptide Drug Marketing Channels Analysis    272
        10.1 Synthesis Polypeptide Drug Marketing Channels Status    272
        10.1.1 Drugs Marketing Channel Developemnt History    272
        10.1.1 Prescription Drug Marketing Development Status    273
        10.2 Synthesis Polypeptide Drug Marketing Channels Management    274
        10.3 Synthesis Polypeptide Drug Marketing Channels Establishment    275
        10.4 Synthesis Polypeptide Drug Marketing Channels Development Trend    276
        Chapter Eleven Synthesis Polypeptide Drug Industry Development Trend    278
        11.1 2012-2016 Synthesis Polypeptide Drug Industry Development Trend    278
        11.2 2012-2016 Market Potential Forecast    279
        11.3 2012-2016 R&D Trend    280
        11.3.1Polypeptide Drug Technical Development Status    280
        11.3.2 Polypeptide Drug and Health Care Products Research and Manufacturing Overview
         282
        11.3.3 China Polypeptide Drug Development Direction and Prospect    283
        11.4 2012-2016 Marketing Channels Change Trend    285
        14.4.1 Prescription Drug Marketing Channels Change Trend    285
        14.4.2 Prescription Drug Sales Method Five Trend    286
        11.5 2012-2016 Competition Pattern Development Trends    288
        Chapter Twelve Synthesis Polypeptide Drug Industry Development Proposals    289
        12.1 Macroeconomic Development Countermeasures    289
        12.2 New Firms Enter Market Strategy    290
        12.2.1 New Business Entry Barriers    290
        12.2.2 New Corporate Strategy    290
        12.3 New Project Investment Proposal    293
        12.4 Marketing Channel Strategy Proposals    294
        12.5 Competitive Environment Strategy Proposals    296
        12.5.1 Competitive Environment Analysis    296
        12.5.2 Strategy Proposals    297
        Chapter Thirteen Synthesis Polypeptide Drug New Project Investment Feasibility Analysis
            300
        13.1 Synthesis Polypeptide Drug Project SWOT Analysis    300
        13.2 Synthesis Polypeptide Drug New Project Investment Feasibility Analysis    302
        13.2.1 Buildings    302
        13.2.2 Investment    303
        13.2.3 Project Schedule    303
        13.2.4 Project Investment Return and Feasibility Analysis    304
        Chapter Fourteen Synthesis Polypeptide Drug Industry Research Conclusions    304

List Of Tables and Figures

Figure Synthesis Polypeptide Process Flow 1
Figure Synthesis Polypeptide Drug Picture-Thymopentin Injection 2
Figure Polypeptide Applications on Health Care Food and Cosmetics Fields 4
Figure Polypeptide Drug Manufacturing Process Method 4
Table Synthesis Polypeptide Drug Classification and Application List 5
Table Synthesis Polypeptide Drug Product Name Use and Annual Sales Revenue (USD) List 6
Table Listed Polypeptide Drug Name Type Indication 6
Figure Pharmaceutical Industry Value Chain Structure 12
Figure Pharmaceutical Industry Industry Chain Structure 12
Figure Synthesis Polypeptide Drug Industry Chain Structure 13
Figure Synthesis Polypeptide Drug Industrialization System 13
Figure 2000-2011 China Pharmaceutical Industry Sales Revenue and Total Profit (100 Million
RMB) and Growth Rate 14 Figure 2007-2015 China Synthesis Polypeptide Drug Market Scale
(100 Million RMB) and Growth Rate 15 Figure DNA Transcribed into RNA Diagram 17
Figure RNA Translated into Polypeptide Chains Molecular Diagram 18
Table Polypeptide Drug Three Manufacturing Methods 19
Figure 1984 Chemistry Nobel Prize Winner Robert Bruce Merrifield 20
Figure Polypeptide Solid Phase Synthesis Principle 20
Figure Solid Phase Polypeptide Synthesis 21
Figure United States CS Three Channel Full Automatic Polypeptide Synthetic Instrument 22
Figure Homemade CS136 Model Research Polypeptide Synthetic Instrument 23
Figure Large Scale Liquid Phase Synthesis of Polypeptide 24
Figure Thin Film Evaporator (for perishable goods Concentration) 24
Table Global 2008 Revenue More than 1 Billion Polypeptide Drug Brands List 25
Table Some Listed Polypeptide Drug Indication Classification 26
Figure Listed Polypeptide Drug Indication Classification Market Share 26
Figure 2004-2014 Global Pharmaceutical Sales Revenue (Billion USD) and Growth Rate 30
Figure 2009-2013 International Synthesis Polypeptide Drug Market Scale (100 Million RMB)
and Growth Rate 31 Table 2011 Some Polypeptide Drug Global Sales Revenue (100 Million USD)
31 Figure Each Year Enter Clinical Research Polypeptide Drug Quantity (Piece) 32
Table 17 Emerging Pharmaceutical Market Sizes (Billion USD) 38
Figure 2007-2015 China Pharmaceutical Sales Revenue (100 Million USD) 39
Figure 2009-2015 China Polypeptide Drug Market Scale (100 Million RMB) and Growth Rate 39
Figure 2009-2015 China Chemical Synthesis Polypeptide Drug Market Scale (100 Million RMB)
and Growth Rate 40 Figure 2009-2015 China Chemical Synthesis Polypeptide Drug Market Scale
(100 Million RMB) and Proportion of China Total Polypeptide Drug Market Scale 41 Figure
2007-2009 China Chemical Synthesis Polypeptide Drug Types Market Share 41 Table Copaxone
Neuron Structure Diagram 44 Table Thymalfasin for Injection (Thymalfasin a1) Suppliers
List 48 Table 2010 Thymalfasin for Injection Key Products Price (RMB/Piece) List 49
Table Some Thymopentin Injection Suppliers List 51
Table Thymopentin Injection Hospital Purchase Price (RMB/Piece) List 52
Table Thymopetidum Injection Thymopentin Injection Thymalfasin Injection Comparison 56
Table Octreotide Acetate Injection Key Suppliers List 59
Table 2012 Hebei Province Octreotide Acetate Injection Bid Price List 60
Tale Somatostatin for Injection Key Suppliers List 64
Table Somatostatin for Injection Key Products Hospital Average Purchae Price List 64
Table 2012 Hebei Province Somatostatin for Injection Key Suppliers List 65
Table Salmon Calcitonin Injection Suppliers List 69
Table Salmon Calcitonin Injection/Nasal Spray Products Hospital Purchase Price List 69
Table Salmon Calcitonin Injection/Nasal spray Products Retail Price List 70
Table Elcatonin Injection Key Suppliers and Product Selling Price List 72
Figure TerfparaLide Injectlon-Forsteo Injection Pen Parts 75
Table 2011Q1 China Some Aproved New Drug Number, Specifications Suppliers and Indication
76 Table 2012 New Add Key Monitoring Drug Table–TerfparaLide Injectlon 76
Table Oxytocin Injection Key Suppliers List 78
Table Oxytocin Injection Suppliers Products Models List 80
Table Carbetocin Injection Suppliers List 83
Table Acetate Atosiban Injection Supplier Product Specification Price List 85
Table Leuprorelin Acetate Microspheres for Injection Suppliers Product Specification Price
List 88 Table Triptorelin Acetate Injection Suppliers Product Specification Price List 94
Table Chorionic Gonadotrophin for Injection Suppliers Product Specifications List 97
Table 2011 Some Hormone Drugs Independent Pricing and Uniform Pricing Comparison 98
Table Desmopressin Acetate Injection Key Suppliers List 100
Table Desmopressin Acetate Injection Key Suppliers Forms Product Specifications and Bid
Price List 101 Table Terlipressin for Injection Key Brands Manufacturers and Retail Prices
104 Table Biosynthetic Glucagon for Injection Suppliers and Retail Prices List 106
Table Exenatide Suppliers Product Specifications Retail Prices List 109
Figure 2007-2015 China Medical Industry Total Production Value (100 Million RMB) and
Growth Rate 110 Table 2006-2011 China GDP (1000 Million RMB) and Growth Rate 110
Figure 2007-2011 China Medical Industry Total Value and Its Proportion of China Total GDP
111 Figure 2007-2015 China Individual Medical Expenditure (RMB) 112
Figure 2007-2015 China Health Expenditure Per Capita and National Medical Expenditure
Comparison 112 Figure 2011-2016 China Population Growth and Aging Condition 113
Figure 2006-2011 Europe Several Countries PMI Trend 114
Figure United States CPI and PCE Growth Comparison 117
Figure United States Private Savings Rate Change and Net Export /GDP Proportion Change
Trend 118 Figure United States Public Debt and Deficit Proportion of GDP 119
Figure Japan GDP and CPI Growth Rate Comparison 119
Figure 2009-2011 China Health Capital Investment (100 Million RMB) 122
Table China Pharmaceutical Industry All major Departments and Regulatory Functions 122
Table Pharmaceutical Industry main Laws and Regulations and Policies 125
Table 2009-2012 China Medical and Health System Reform Important Policy 128
Table 2009-2012 China Related Pharmaceutical Product Quality Supervision Policy 129
Table 2008-2012 China Development and Reform Commission Policy on Drug Price Management
Policies 130 Figure PTIPolypeptide Synthetic Instruments Picture 133
Table Synthesis Polypeptide Drug Technology Processes List 133
Figure Polypeptide Pharmaceutical Raw Materials Manufacturing Process Flow 135
Figure Freeze Dried Powder Injection Manufacturing Process Flow 136
Figure Small Capacity Injection Manufacturing Process Flow 136
Figure Thymalfasin API Manufacturing Process Flow 137
Figure Thymalfasin Injection Manufacturing Process Flow 138
Figure International Synthesis Polypeptide Drug Cost Structure 139
Table 2009-2011 China Synthesis Polypeptide Drug Cost Structure 139
Table 2009-2013 Global Key Manufacturers Synthesis Polypeptide Drug Capacity and Total
Capacity (10K Piece) List 140 Table 2009-2013 Global Key Manufacturers Synthesis
Polypeptide Drug Capacity Market Share List 140 Table 2009-2013 Global Key Manufacturers
Synthesis Polypeptide Drug Production and Total Production (10K Piece) List 141 Table
2009-2013 Global Key Manufacturers Synthesis Polypeptide Drug Production Market Share List
141 Table 2009-2013 China Key Manufacturers Synthesis Polypeptide Drug Capacity and Total
Capacity (10K Piece) List 142 Table 2009-2013 China Key Manufacturers Synthesis
Polypeptide Drug Capacity Market Share List 142 Table 2009-2013 China Key Manufacturers
Synthesis Polypeptide Drug Production and Total Production (10K Piece) List 143 Table
2009-2013 China Key Manufacturers Synthesis Polypeptide Drug Production Market Share List
143 Figure 2009-2013 Global Synthesis Polypeptide Drug Capacity Production (10K Piece) and
Growth Rate 144 Table 2009-2013 Global Synthesis Polypeptide Drug Capacity Utilization
Rate List 144 Figure 2009-2013 China Synthesis Polypeptide Drug Capacity Production (10K
Piece) and Growth Rate 145 Table 2009-2013 China Synthesis Polypeptide Drug Capacity
Utilization Rate List 145 Table 2009-2013 Key Manufacturers Synthesis Polypeptide Drug
China Sales (10K Piece) Top20 List 146 Table 2009-2013 Key Manufacturers Synthesis
Polypeptide Drug China Sales Top20 Market Share List 147 Table 2010 Key Manufacturers
Synthesis Polypeptide Drug China Sales Revenue (100 Million RMB) Top10 List 147 Table
2008-2010 Key Manufacturers Synthesis Polypeptide Drug China Sales Revenue Top10 Market
Share List 148 Figure 2011 Key Manufacturers Synthesis Polypeptide Drug China Sales Market
Share 149 Figure 2012 Key Manufacturers Synthesis Polypeptide Drug China Sales TOP20
Market Share 150 Figure 2011 China Key Manufacturers Synthesis Polypeptide Drug Production
Market Share 151 Figure 2012 China Key Manufacturers Synthesis Polypeptide Drug Production
Market Share 151 Table 2009-2013 Global Synthesis Polypeptide Drug Demand (10K Piece) and
Growth Rate 152 Table 2009-2013 China Synthesis Polypeptide Drug Demand (10K Piece) and
Growth Rate 152 Table 2009-2013 China Synthesis Polypeptide Drug Supply Demand and
Shortage (10K Piece) 153 Table 2009-2013 Nine Foreign Enterprises Synthesis Polypeptide
Drug China Sales (10K Piece) List 153 Table 2009-2013 China Synthesis Polypeptide Drug
Production Import Export Consumption (10K Piece) List 154 Table 2007-2009 China Synthesis
Polypeptide Drug Price (RMB/Piece) Distribution 154 Table 2009-2011 Hainan Shuangcheng
Pharmaceuticals Some Synthesis Polypeptide Drug Price Cost (RMB/Piece) Gross Margin List
155 Table 2009-2013 China Synthesis Polypeptide DrugProduction (10K Piece) Price Cost
Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 155 Figure 2011 China
Synthesis Polypeptide Drug Market Share by Different Type Drug 156 Figure 2008-2014 China
Thymopentin Injection Market Scale (100 Million RMB) and Growth Rate 157 Figure 2008-2014
China Thymopentin Injection Sales (10K Piece) and Growth Rate 157 Figure 2008-2014 China
Thymalfasin Injection Market Scale (100 Million RMB) and Growth Rate 158 Figure 2008-2014
China Thymalfasin Injection Sales (10K Piece) and Growth Rate 159 Figure 2008-2014 China
Calcitonin Injection Market Scale (100 Million RMB) and Growth Rate 160 Figure 2008-2014
China Calcitonin Injection Sales (10K Piece) and Growth Rate 160 Figure 2008-2014 China
Somatostatin for Injection Market Scale (100 Million RMB) and Growth Rate 161 Figure
2008-2014 China Somatostatin for Injection Sales (10K Piece) and Growth Rate 162 Figure
2008-2014 China Octreotide Acetate Injection Market Scale (100 Million RMB) and Growth
Rate 163 Figure 2008-2014 China Octreotide Acetate Injection Sales (10K Piece) and Growth
Rate 163 Figure 2008-2014 China Desmopressin Acetate Injection Market Scale (100 Million
RMB) and Growth Rate 164 Figure 2008-2014 China Desmopressin Acetate Injection Sales (10K
Piece) and Growth Rate 164 Table 2009-2011 China Chemical Synthesis Polypeptide Drug
Injection Distribution List 165 Figure 2010 Global Polypeptide Drug Market Structure by
Treatment Class 165 Table Research or Listed Polypeptide Drugs List 166
Figure 1990-2010 China Resident Three Types of Chronic Disease Prevalence (1/100K) Change
Trend 167 Figure 2010 China Synthesis Polypeptide Drug Hospital Terminal Sales Market
Share Distribution 168 Figure 2010 China Synthesis Polypeptide Drug Top10 Manufacturers
Sales Revenue (100 Million RMB) 168 Figure China Synthesis Polypeptide Drug Prices
Distribution 169 Figure Use Me-Too Model Developed Polypeptide Drug List 169
Table Novartis Company Information Table (Products Applications Manufacturing Base
Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 170
Figure Novartis China Market Sales Synthesis Polypeptide Drug–Octreotide Acetate
Injection 173 Figure Novartis China Market Sales Synthesis Polypeptide Drug–Somatostatin
Acetate for Injection 173 Figure Novartis China Market Sales Synthesis Polypeptide
Drug–salmon Calcitonin Nasal Spray 174 Table 2009-2013 Novartis Synthesis Polypeptide
Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross
Margin List 174 Figure 2009-2013 Novartis Synthesis Polypeptide Drug Capacity Production
(10K Piece) and Growth Rate 175 Table Merck Serono Company Information Table (Products
Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact
Information etc 13 Items) 176 Figure Merck Serono Synthesis Polypeptide Drug–Recombinant
Human Follitropin Alfa Solution for Injection 178 Figure Merck Serono Synthesis
Polypeptide Drug–Somatostatin for Injection 179 Figure Merck Serono Synthesis Polypeptide
Drug–Gonadorelin for Injection 179 Table 2009-2013 Merck Serono Synthesis Polypeptide
Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross
Margin List 180 Figure 2009-2013 Merck Serono Synthesis Polypeptide Drug Capacity
Production (10K Piece) and Growth Rate 181 Table Ferring Pharmaceuticals Company
Information Table (Products Applications Manufacturing Base Location Capacity Expansion
Plan Market Position Contact Information etc 13 Items) 182 Figure Ferring Pharmaceuticals
China Market Sales Synthesis Polypeptide Drug–Minirin 183 Figure Ferring Pharmaceuticals
China Market Sales Synthesis Polypeptide Drug–Decapeptyl 184 Figure Ferring
Pharmaceuticals China Market Sales Synthesis Polypeptide Drug–Pentasa 184 Figure Ferring
Pharmaceuticals China Market Sales Synthesis Polypeptide Drug–Glypressin 185 Figure
Ferring Pharmaceuticals China Market Sales Synthesis Polypeptide Drug–Octostim 186 Table
2009-2013 Ferring Pharmaceuticals Synthesis Polypeptide Drug Production (10K Piece) Cost
Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 186 Figure 2009-2013
Ferring Pharmaceuticals Synthesis Polypeptide Drug Capacity Production (10K Piece) and
Growth Rate 188 Table Ipsen PHarma Biotech Company Information Table (Products
Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact
Information etc 13 Items) 188 Figure Ipsen PHarma Biotech Synthesis Polypeptide
Drug–Triptorelin Acetate for Injection 190 Table 2009-2013 Ipsen PHarma Biotech Synthesis
Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K
RMB) Gross Margin List 190 Figure 2009-2013 Ipsen PHarma Biotech Synthesis Polypeptide
Drug Capacity Production (10K Piece) and Growth Rate 191 Table Lilly Company Information
Table (Products Applications Manufacturing Base Location Capacity Expansion Plan Market
Position Contact Information etc 13 Items) 192 Figure Lilly Some China Listed Synthesis
Polypeptide Drug List 194 Table 2009-2013 Lilly Synthesis Polypeptide Drug Production (10K
Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 194
Figure 2009-2013 Lilly Synthesis Polypeptide Drug Capacity Production (10K Piece) and
Growth Rate 195 Table Asahi Kasei Company Information Table (Products Applications
Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information
etc 13 Items) 195 Figure Asahi Kasei Synthesis Polypeptide Drug–Elcatonin Injection 198
Table 2009-2013 Asahi Kasei Synthesis Polypeptide Drug Production (10K Piece) Cost Price
Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 198 Figure 2009-2013 Asahi
Kasei Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 199 Table
AstraZeneca Company Information Table (Products Applications Manufacturing Base Location
Capacity Expansion Plan Market Position Contact Information etc 13 Items) 199 Figure
AstraZeneca China Selling Synthesis Polypeptide Drug-Goserelin Acetate Slow Release
Implantation Agent 201 Table 2009-2013 Jiangsu AstraZeneca Synthesis Polypeptide Drug
Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross
Margin List 202 Figure 2009-2013 Jiangsu AstraZeneca Synthesis Polypeptide Drug Capacity
Production (10K Piece) and Growth Rate 203 Table SciClone Pharmaceuticals Company
Information Table (Products Applications Manufacturing Base Location Capacity Expansion
Plan Market Position Contact Information etc 13 Items) 204 Figure SciClone Pharmaceuticals
Synthesis Polypeptide Drug– Thymopetidum alpha ` Injection 205 Table 2009-2013 SciClone
Pharmaceuticals Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross
(RMB/Piece) Production Value (10K RMB) Gross Margin List 205 Figure 2009-2013 SciClone
Pharmaceuticals Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate
206 Table Takeda Company Information Table (Products Applications Manufacturing Base
Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 206
Figure Takeda–Leuprorelin Acetate Microspheres for Injection 208
Table 2009-2013 Takeda Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross
(RMB/Piece) Production Value (10K RMB) Gross Margin List 209 Figure 2009-2013 Takeda
Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 209 Table HYBIO
Pharmaceutical Co.,Ltd Company Information Table (Products Applications Manufacturing Base
Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 210
Figure 2009-2013 HYBIO Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug 211
Table 2009-2013 HYBIO Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K
Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 213
Figure 2009-2013 HYBIO Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity
Production (10K Piece) and Growth Rate 215 Table Hainan Zhonghe Pharmaceutical Co.,Ltd
Company Information Table (Products Applications Manufacturing Base Location Capacity
Expansion Plan Market Position Contact Information etc 13 Items) 216 Figure Hainan Zhonghe
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug ” 217 Table 2009-2013 Hainan Zhonghe
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross
(RMB/Piece) Production Value (10K RMB) Gross Margin List 217 Figure 2009-2013 Hainan
Zhonghe Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K Piece)
and Growth Rate 219 Table Sichuan Chengdu Diao Pharmaceutical Group Co.,Ltd Company
Information Table (Products Applications Manufacturing Base Location Capacity Expansion
Plan Market Position Contact Information etc 13 Items) 219 Figure Sichuan Chengdu Diao
Pharmaceutical Group Co.,Ltd Synthesis Polypeptide Drug-Thymalfasin Injection 221 Figure
Sichuan Chengdu Diao Pharmaceutical Group Co.,Ltd Synthesis Polypeptide Drug-Thymopentin
Injection 222 Table 2009-2013 Sichuan Chengdu Diao Pharmaceutical Group Co.,Ltd Synthesis
Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K
RMB) Gross Margin List 222 Figure 2009-2013 Sichuan Chengdu Diao Pharmaceutical Group
Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 223
Table Beijing Yingu Century Pharmaceutical Co.,Ltd Company Information Table (Products
Applications Manufacturing Base Location Capacity Expansion Plan Market Position Contact
Information etc 13 Items) 224 Figure Beijing Yingu Century Pharmaceutical Co.,Ltd
Synthesis Polypeptide Drug-Salmon Calcitonin Nasal Spray 225 Figure Beijing Yingu Century
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Thymopentin Injection 226 Table
2009-2013 Beijing Yingu Century Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug
Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross
Margin List 226 Figure 2009-2013 Beijing Yingu Century Pharmaceutical Co.,Ltd Synthesis
Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 227 Table Hainan
Shuangcheng Pharmaceuticals Co.,Ltd Company Information Table (Products Applications
Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information
etc 13 Items) 228 Figure Hainan Shuangcheng Pharmaceuticals Co.,Ltd Synthesis Polypeptide
Drug–Thymalfasin Injection 229 Figure Hainan Shuangcheng Pharmaceuticals
Co.,Ltd Synthesis Polypeptide Drug-Somatostatin for Injection 231 Figure Hainan
Shuangcheng Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug-Thymopentin Injection
232 Table 2009-2013 Hainan Shuangcheng Pharmaceuticals Co.,Ltd
Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production
Value (10K RMB) Gross Margin List 233 Figure 2009-2013 Hainan Shuangcheng Pharmaceuticals
Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 234
Table Livzon Pharmaceuticals Co.,Ltd Company Information Table (Products Applications
Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information
etc 13 Items) 234 Figure Livzon Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug 236
Table 2009-2013 Livzon Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug Production (10K
Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 236
Figure 2009-2013 Livzon Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug Capacity
Production (10K Piece) and Growth Rate 238 Table Wuhan Hualong Bio-Chemical Pharmaceutical
Co.,Ltd Company Information Table (Products Applications Manufacturing Base Location
Capacity Expansion Plan Market Position Contact Information etc 13 Items) 239 Figure Wuhan
Hualong Bio-Chemical Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug–Thymopentin
Injection 240 Figure Wuhan Hualong Bio-Chemical Pharmaceutical Co.,Ltd Synthesis
Polypeptide Drug–Somatostatin for Injection 240 Table 2009-2013 Wuhan Hualong
Bio-Chemical Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost
Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 241 Figure 2009-2013
Wuhan Hualong Bio-Chemical Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity
Production (10K Piece) and Growth Rate 242 Table Chengdu Tiantaishan Pharmaceutical
Co.,Ltd Company Information Table (Products Applications Manufacturing Base Location
Capacity Expansion Plan Market Position Contact Information etc 13 Items) 242 Figure
Chengdu Tiantaishan Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Somatostatin for
Injection 244 Figure Chengdu Tiantaishan Pharmaceutical Co.,Ltd Synthesis Polypeptide
Drug-Thymopentin Injection 246 Figure Chengdu Tiantaishan Pharmaceutical Co.,Ltd Synthesis
Polypeptide Drug-Octreotide Acetate Injection 247 Table 2009-2013 Chengdu Tiantaishan
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross
(RMB/Piece) Production Value (10K RMB) Gross Margin List 248 Figure 2009-2013 Chengdu
Tiantaishan Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K
Piece) and Growth Rate 249 Table Beijing Shuanglu Pharmaceutical Co.,Ltd Company
Information Table (Products Applications Manufacturing Base Location Capacity Expansion
Plan Market Position Contact Information etc 13 Items) 250 Figure Beijing Shuanglu
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Thymopentin Injection 251 Figure Beijing
Shuanglu Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Salmon Calcitonin Injection 252
Table Beijing Shuanglu Pharmaceutical Co.,Ltd Thymopentin Injection Price List 253
Table 2009-2013 Beijing Shuanglu Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug
Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross
Margin List 256 Figure 2009-2013 Beijing Shuanglu Pharmaceutical Co.,Ltd Synthesis
Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 257 Table Yangzijiang
Pharmaceutical Co.,Ltd Company Information Table (Products Applications Manufacturing Base
Location Capacity Expansion Plan Market Position Contact Information etc 13 Items) 257
Figure Yangzijiang Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Somatostatin for
Injection 259 Figure Yangzijiang Pharmaceutical Co.,Ltd Synthesis Polypeptide
Drug-Thymopentin Injection 260 Table 2009-2013 Yangzijiang Pharmaceutical Co.,Ltd
Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production
Value (10K RMB) Gross Margin List 260 Figure 2009-2013 Yangzijiang Pharmaceutical Co.,Ltd
Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 261 Table
Changzhou Siyao Pharmaceutical Co.,Ltd Company Information Table (Products Applications
Manufacturing Base Location Capacity Expansion Plan Market Position Contact Information
etc 13 Items) 262 Figure Changzhou Siyao Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug
List 264 Table Changzhou Siyao Pharmaceutical Co.,Ltd Chemical Pharmaceutical Raw
Materials List 264 Table Changzhou Siyao Pharmaceutical Co.,Ltd Chemical Raw Materials
Intermediates List 265 Table 2009-2013 Changzhou Siyao Pharmaceutical Co.,Ltd Synthesis
Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production Value (10K
RMB) Gross Margin List 266 Figure 2009-2013 Changzhou Siyao Pharmaceutical Co.,Ltd
Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 266 Table
Synthesis Polypeptide Drug Project Key Equipments and Price (10K RMB) 269 Table Synthesis
Polypeptide Drug Project Equipments List and Price (10K RMB) 270 Table Drugs Manufacturing
Enterprise Specialized Academic Promotion Organization Frame 276 Figure Synthesis
Polypeptide Drug Industry Entry Barriers List 293 Table 2012 China Synthesis Polypeptide
Drug New Project SWOT Analysis 300 Table 2012 China Synthesis Polypeptide Drug New Project
Buildings List 302 Table 2012 China Synthesis Polypeptide Drug New Project Investments
(10K RMB) List 303 Table Synthesis Polypeptide Drug New Project Investment Return and
Feasibility Analysis 304

Browse more reports on the Pharmaceuticals Market @

http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals.

Explore newly published market research reports on other industries and for different
geographies @ http://www.rnrmarketresearch.com/latest_reports.

About Us:

RnRMarketResearch.com (http://www.rnrmarketresearch.com) is an online market
research reports library of 175,000+ in-depth studies of over 5000 micro markets. Our
database includes reports by leading publishers from across the globe. We provide 24/7
online and offline support service to our customers.

        Contact:
        Priyank Tiwari
        TX, Dallas North - Dominion Plaza,
        17304, Preston Road,
        Suite 800, Dallas 75252
        Tel: +1-888-391-5441
        sales@rnrmarketresearch.com
        Explore more Industry reports @ http://www.marketreportsonline.com.

SOURCE RnRMarketResearch


Source: PR Newswire